Poseida Therapeutics, Inc.
NASDAQ:PSTX
3.51 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -123.43 | -64.002 | -124.974 | -129.775 | -86.527 | -44.404 | -19.662 | -4.575 |
| Depreciation & Amortization
| 5.614 | 5.172 | 4.552 | 2.586 | 1.193 | 0.689 | 0.676 | 0.22 |
| Deferred Income Tax
| -1.115 | 0 | -19.632 | 0.213 | 0.784 | -0.202 | -0.528 | -0.167 |
| Stock Based Compensation
| 23.134 | 18.926 | 16.704 | 7.22 | 3.05 | 0.975 | 0.4 | 0.303 |
| Change In Working Capital
| 14.081 | 13.715 | 20.168 | 5.623 | 9.467 | 0.718 | -1.851 | -5.72 |
| Accounts Receivables
| 0.077 | -9.088 | 0 | 0 | 0 | 0 | 0.865 | -0.289 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | -0.124 | 0 |
| Accounts Payables
| 1.038 | -6.748 | 7.842 | -4.171 | 1.53 | 1.004 | -0.041 | 0.954 |
| Other Working Capital
| 12.966 | 29.551 | 12.326 | 9.794 | 7.937 | -0.286 | -2.551 | -6.385 |
| Other Non Cash Items
| 21.681 | -0.583 | 0.639 | 0.805 | 7.643 | 4.21 | -1.732 | 0.029 |
| Operating Cash Flow
| -92.167 | -26.772 | -102.543 | -113.328 | -64.39 | -38.014 | -22.697 | -9.988 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -3.066 | -3.924 | -2.634 | -16.908 | -5.156 | -1.284 | -0.201 | -1.809 |
| Acquisitions Net
| 0 | 0.012 | 0.018 | 187.523 | 37.308 | 0 | 0 | -0.55 |
| Purchases Of Investments
| -237.8 | -294.422 | -0.018 | -295.023 | -71.436 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 280 | 95 | 225 | 107.5 | 34 | 0 | 0 | 0 |
| Other Investing Activites
| 42.2 | -199.41 | 0.018 | -187.523 | -37.308 | 0 | 0 | 0 |
| Investing Cash Flow
| 39.134 | -203.334 | 222.384 | -204.431 | -42.592 | -1.284 | -0.201 | -2.359 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | -0.001 | 0 | 0 | -9.947 | -9.405 | -9.79 | 0 |
| Common Stock Issued
| 16.621 | 75.299 | 2.518 | 205.743 | 149.782 | 29.713 | 11.446 | 8.586 |
| Common Stock Repurchased
| -0.494 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.494 | 29.861 | 2.518 | 108.198 | 24.536 | 54.068 | 20.63 | 8.586 |
| Financing Cash Flow
| 16.127 | 105.159 | 2.518 | 313.941 | 164.371 | 54.068 | 20.63 | 8.586 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 |
| Net Change In Cash
| -36.906 | -124.947 | 122.359 | -3.818 | 57.389 | 14.77 | -2.267 | -3.761 |
| Cash At End Of Period
| 44.472 | 81.378 | 206.325 | 83.966 | 87.784 | 30.395 | 15.625 | 17.892 |